Can a blood test reveal hidden links between childhood trauma and suicide risk?
NCT ID NCT04923685
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at how childhood trauma and stress affect tiny genetic molecules called microRNAs in the blood. Researchers will compare people with major depression and healthy volunteers to see if these molecules can help explain the link between early life stress and suicidal thoughts. The goal is to better understand the biology behind mental illness, not to test a new treatment.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could help identify biological markers that predict depression or suicide risk after childhood trauma.
- What could go wrong
- This is an observational study, not a treatment trial. It may not lead to direct clinical changes, and results may not apply to all populations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 450 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Feb 2021
- Expected to finish
-
Dec 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
People between the ages of 18 and 60 with either a history of Major Depressive Disorder or no lifetime history of any major mental illness.
- Ages
-
18 to 60 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Age 18-60 2. Physically healthy 3. Willing and able to provide informed consent 5\. Diagnosis of MDD or No history of mental illness Exclusion Criteria: 1. Pregnancy or lactation (women of reproductive potential must have a negative urine pregnancy screen) 2. Post-partum state (being within 2 months of delivery or miscarriage) 3. Homicide risk as determined by clinical interview 4. A lifetime history of psychotic disorder 5. Any history of dissociation or dissociative disorder 6. Bipolar disorder 7. Pervasive developmental disorder 8. Cognitive disorder 9. Cluster A personality disorder 10. Borderline personality disorder 11. Anorexia nervosa 12. Alcohol or drug dependence (except nicotine and caffeine) within the last month or the use of any hallucinogen (except cannabis), including phencyclidine in the last month (NOTE that a positive UDS is not exclusionary except for hallucinogens, methamphetamine, or cocaine. People presenting intoxicated with alcohol may be included when a Breathalyzer test (Alco-Sensor IV) is negative as long as there is no history of recent dependence. 13. Recent myocardial infarction 14. Unstable angina 15. Active neoplasm in the past 6 months 16. Immunosuppressive or corticosteroid therapy within the last month, with the following exceptions: any inhaled, intranasal, topical or vaginal corticosteroids are allowed. 17. Chemotherapy 18. Head injury with loss of consciousness in the past 6 months
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Major depressive disorder are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
2 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
UAB Huntsville Regional Medical Campus
RECRUITINGHuntsville, Alabama, 35294, United States
-
University of Alabama at Birmingham
RECRUITINGBirmingham, Alabama, 35233, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Intramuscular ketamine for suicidal patients in the evanston hospital emergency department for suicidal distress: a pilot study
- Targeting the brain's reward system: a new test for depression treatment
- Can brain activity reveal why some people with depression lose motivation and pleasure?
- Can sound, heat, and pressure rewire the depressed brain?
- Can two natural supplements boost antidepressants?
- Can a short talk therapy boost TB recovery?